PAR 12.7% 31.0¢ paradigm biopharmaceuticals limited..

Ann: Primary and Secondary endpoints met in MPS I Trial, page-29

  1. 5,933 Posts.
    lightbulb Created with Sketch. 1138
    Cheers ruff

    Throw some money our way India...
    Last edited by oxxa23: 07/06/23
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.